Citalopram 20mg

DRUG8 trials

Sponsors

The University of Texas Health Science Center, Houston, Universitaire Ziekenhuizen KU Leuven, University of Michigan, Hospital Regional 1o de Octubre, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions

AnhedoniaBurning Mouth SyndromeCocaine AbuseFunctional Chest PainGERDHealthyHot FlashesOpiate Dependence

Phase 1

REward Processing And Citalopram Study

University of OxfordAnhedonia

Start: 2023-05-19End: 2024-05-01Target: 40Updated: 2023-08-30

Phase 2

Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8

TerminatedNCT00218036

The University of Texas Health Science Center, HoustonCocaine Abuse, Opiate Dependence

Start: 2006-07-31End: 2010-02-28Updated: 2018-11-16

Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease

CompletedNCT04497168

University of MichiganParkinson Disease

Start: 2021-04-01End: 2026-03-02Updated: 2026-03-16

Phase 3

Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome

Federico II UniversityBurning Mouth Syndrome

Start: 2023-01-01End: 2024-07-24Target: 203Updated: 2023-09-06

Phase 4

Citalopram for Reflux Hypersensitivity and Functional Heartburn

Universitaire Ziekenhuizen KU LeuvenGERD

Start: 2019-05-27End: 2021-04-30Target: 100Updated: 2019-12-05

Effect of Citalopram on Chest Pain in Patients With Functional Chest Pain

TerminatedNCT05735756

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Functional Chest Pain

Start: 2022-01-17End: 2022-04-22Updated: 2023-02-21

Unknown Phase

Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome

CompletedNCT05346445

Hospital Regional 1o de OctubreHot Flashes, Postmenopause

Start: 2021-01-20End: 2021-12-20Updated: 2022-07-26

Serotonin, Anxiety and Visceral Sensation

CompletedNCT06212284

University of SussexHealthy

Start: 2018-02-18End: 2018-11-14Updated: 2024-01-25

Related Papers

Vortioxetine versus SSRI/SNRI with Pregabalin Augmentation in Treatment-Resistant Burning Mouth Syndrome: A Prospective Clinical Trial

Current Neuropharmacology2025-02-283 citations

Citalopram improves vasomotor syndrome and urogenital syndrome of menopause in Mexican women: a randomized clinical trial.

2022-08-232 citations